Measles vaccine vectors and methods of use

dc.contributor.authorRoss, Ted
dc.contributor.authorRobinson, Harriet
dc.date.accessioned2019-11-11T18:38:40Z
dc.date.available2019-11-11T18:38:40Z
dc.date.issued2003-03-20
dc.description.abstractThe present invention provides a novel vaccine expressing a fusion of the measles hemagglutinin (H) protein and the complement component, C3d, to enhance the titers of neutralizing antibody. Plasmids were generated that expressed a secreted (s) form of H and the same form fused to three tandem copies of the murine homologue of C3d (sH-3C3d). Analysis of titers of the antibody raised in vaccinated mice indicated that groups vaccinated with the DNA construct expressing sH-3C3d had higher titers of anti-H antibodies compared to serum from mice vaccinated with DNA expressing sH only. In addition, sH-3C3d elicited higher neutralizing antibody titers that inhibited MV induced plaque formation.en_US
dc.identifier.otherInternational Publication #WO2003022204A2
dc.identifier.otherUS Pat# US28262101P
dc.identifier.urihttp://hdl.handle.net/10342/7541
dc.language.isoen_USen_US
dc.relation.urihttps://patents.google.com/patent/WO2003022204A2/en?oq=inassignee:%22East+Carolina%22en_US
dc.subjectimmunizationen_US
dc.subjectVaccineen_US
dc.titleMeasles vaccine vectors and methods of useen_US
dc.typePatenten_US

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
WO2003022204A2.pdf
Size:
2.27 MB
Format:
Adobe Portable Document Format
Description:
International patent application